J C Reeder Selected Research

Plasmodium falciparum EMP3 protein

6/2000

Targeted mutagenesis of Plasmodium falciparum erythrocyte membrane protein 3 (PfEMP3) disrupts cytoadherence of malaria-infected red blood cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

J C Reeder Research Topics

Disease

5	Malaria 09/2006 - 01/2000
2	Infections 01/2001 - 01/2000
1	Falciparum Malaria (Plasmodium falciparum Malaria) 01/2009
1	Vivax Malaria 01/2009
1	Acidosis 09/2006
1	Cerebral Malaria 09/2006
1	Hypoxia (Hypoxemia) 09/2006

Drug/Important Bio-Agent (IBA)

2	AntigensIBA 01/2009 - 06/2001
2	Membrane Proteins (Integral Membrane Proteins)IBA 01/2009 - 06/2001
2	VaccinesIBA 06/2001 - 03/2001
1	Muscle Proteins (Muscle Protein)IBA 09/2006
1	MyoglobinIBA 09/2006
1	AntibodiesIBA 06/2001
1	Proteins (Proteins, Gene)FDA Link 06/2001
1	Malaria VaccinesIBA 03/2001
1	Sulfadoxine (Sulformethoxine)FDA Link 01/2001
1	Pyrimethamine (Daraprim)FDA Link 01/2001
1	pyrimethamine drug combination fanasil (Fansidar)FDA Link 01/2001
1	Plasmodium falciparum EMP3 proteinIBA 06/2000
1	Hyaluronic Acid (Hyaluronan)IBA 01/2000